Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial

Autor: Roufosse, Florence, Kahn, Jean-Emmanuel, Rothenberg, Marc E., Wardlaw, Andrew J., Klion, Amy D., Kirby, Suyong Yun, Gilson, Martyn J., Bentley, Jane H., Bradford, Eric S., Yancey, Steven W., Steinfeld, Jonathan, Gleich, Gerald J.

Publikováno v: In The Journal of Allergy and Clinical Immunology December 2020 146(6):1397-1405

Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool

Autor: Kovacs, Nicholas, Benjamin, Katy, Holland-Thomas, Nicole, Moshkovich, Olga, Nelsen, Linda M., Ortega, Hector, Schwartz, Ethan J., Steinfeld, Jonathan, Kirby, Suyong Yun, Klion, Amy, Khoury, Paneez

Publikováno v: In The Journal of Allergy and Clinical Immunology: In Practice October 2020 8(9):3209-3212

Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma

Autor: David A, Stempel, Stanley J, Szefler, Søren, Pedersen, Robert S, Zeiger, Anne M, Yeakey, Laurie A, Lee, Andrew H, Liu, Herman, Mitchell, Kenneth M, Kral, Ibrahim H, Raphiou, Barbara A, Prillaman, Kathleen S, Buaron, Suyong, Yun Kirby, Steven J, Pascoe, John F, Zwetchkenbaum

Publikováno v: Stempel, D A, Szefler, S J, Pedersen, S, Zeiger, R S, Yeakey, A M, Lee, L A, Liu, A H, Mitchell, H, Kral, K M, Raphiou, I H, Prillaman, B A, Buaron, K S, Yun Kirby, S Y K & Pascoe, S J 2016, ' Safety of adding salmeterol to fluticasone propionate in children with asthma ', The New England Journal of Medicine, vol. 375, no. 9, pp. 840-849 . https://doi.org/10.1056/NEJMoa1606356

BACKGROUND Long-acting beta-agonists (LABAs) have been shown to increase the risk of asthmarelated death among adults and the risk of asthma-related hospitalization among children. It is unknown whether the concomitant use of inhaled glucocorticoids

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c4fb6f7c12f52b273dda5a58a04dbb
https://doi.org/10.1056/nejmoa1606356

LATE-BREAKING ABSTRACT: Safety of salmeterol/fluticasone propionate (FSC) compared to fluticasone propionate (FP) in 4-17 yr olds with asthma

Autor: Ibrahim Raphiou, Steven Pascoe, Anne Yeakey, Kenneth M. Kral, Søren Pedersen, Robert S. Zeiger, Suyong Yun Kirby, Laurie Lee, Barbara A. Prillaman, D. Stempel, Andrew H. Liu, Kathleen S. Buaron, Herman Mitchell, Stanley J. Szefler

Publikováno v: 7.2 Paediatric Asthma and Allergy.

Background: Studies have shown an excess of serious asthma events in subjects taking long-acting β 2 -agonist (LABAs). In children the excess was in hospitalizations but studies were not designed to detect if risk is mitigated with concomitant use o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b046954a344548758d2c1e9c608c7c6c
https://doi.org/10.1183/13993003.congress-2016.oa4798

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.